Clinical trials recruiting for Small Cell Carcinoma of Lung
3
Recruiting trials
3
US states with sites
3
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 2 1Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| AVA6103 | 1 |
| Atezolizumab, Etoposide, Carboplatin, Tarlatamab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Michigan | 1 |
| Texas | 1 |
| Virginia | 1 |
Top cities
Self-screener
Recruiting trials
- AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
- Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment
- Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients From Adenocarcinoma After EGFR TKI Treatment
Related conditions
Trials recruiting for Small Cell Carcinoma of Lung often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180PDAC - Pancreatic Ductal Adenocarcinoma 21Pancreatic cancer 870Non-Small Cell Carcinoma of Lung 3Hormone Receptor Positive Breast Carcinoma 13Gastric Adenocarcinoma 13Colorectal cancer 1359Breast cancer 2239
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Small Cell Carcinoma of Lung trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.